Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / ALNA - Allena Pharmaceuticals: Rating This Stock A Buy


ALNA - Allena Pharmaceuticals: Rating This Stock A Buy

Allena Pharmaceuticals (ALNA) was founded in 2011 and is based in Newton, Massachusetts. The company's development pipeline is focused on the development, discovery, and commercialization of oral enzyme therapeutics to treat patients with kidney diseases. Its lead product candidate is Reloxaliase, an oral enzyme therapeutic for the treatment of enteric hyperoxaluria ((EH)) in adults. For the purpose of this article, I should focus on the EH pipeline of the company.

Data by YCharts

Scope of the problem:

Hyperoxaluria is characterized by high levels of oxalate in the plasma. In healthy individuals, up to

Read more ...

Stock Information

Company Name: Allena Pharmaceuticals Inc.
Stock Symbol: ALNA
Market: NASDAQ
Website: allenapharma.com

Menu

ALNA ALNA Quote ALNA Short ALNA News ALNA Articles ALNA Message Board
Get ALNA Alerts

News, Short Squeeze, Breakout and More Instantly...